Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience

► Introduction of a new meningitis vaccine in Burkina Faso in 2010 was a huge success. ► More than 11 million Burkinabe (100% target population) were vaccinated in 10 days. ► Early planning (2-3 years), public and political support were key to campaign success. ► WHO played a central role ensuring effective collaboration across myriad of partners.